{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,4]],"date-time":"2026-07-04T01:53:12Z","timestamp":1783129992219,"version":"3.54.6"},"reference-count":34,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"11","license":[{"start":{"date-parts":[[2025,8,21]],"date-time":"2025-08-21T00:00:00Z","timestamp":1755734400000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2025,11]]},"abstract":"<jats:sec>\n            <jats:title>Background:<\/jats:title>\n            <jats:p>To explore the potential utility of <jats:sup>18<\/jats:sup>F-AlF-NOTA-fibroblast activation protein inhibitor (FAPI)-04 PET\/CT (denoted as <jats:sup>18<\/jats:sup>F-FAPI-04 PET\/CT) in the evaluation of cervical cancer through a head-to-head comparison with <jats:sup>18<\/jats:sup>F-FDG PET\/CT for detecting primary tumors and metastatic lymph nodes.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Patients and Methods:<\/jats:title>\n            <jats:p>A total of 22 patients with a pathologic diagnosis of cervical cancer underwent <jats:sup>18<\/jats:sup>F-FDG PET\/CT and <jats:sup>18<\/jats:sup>F-FAPI-04 PET\/CT within a 7-day period. Out of the 22 patients, 19 (median age, 62.3 y) were included in the final analysis. Comparisons were made between the ability of <jats:sup>18<\/jats:sup>F-FDG PET\/CT and <jats:sup>18<\/jats:sup>F-FAPI-04 PET\/CT to detect primary lesions and metastatic lymph nodes; semiquantitative PET\/CT parameters were also analyzed, including SUV<jats:sub>max<\/jats:sub>, SUV<jats:sub>mean<\/jats:sub>, metabolic tumor volume (MTV for <jats:sup>18<\/jats:sup>F-FDG) and fibroblast tumor volume (FTV for <jats:sup>18<\/jats:sup>F-FAPI-04), tumor lesion glycolysis (TLG for <jats:sup>18<\/jats:sup>F-FDG) and tumor lesion FAPI (TLF for <jats:sup>18<\/jats:sup>F-FAPI-04), and tumor-to-background ratios (TBR<jats:sub>liver<\/jats:sub> and TBR<jats:sub>blood<\/jats:sub>), calculated by dividing the SUV<jats:sub>max<\/jats:sub> of the lesion by the SUV<jats:sub>mean<\/jats:sub> of normal liver or blood pool.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Results:<\/jats:title>\n            <jats:p>\n                                 <jats:sup>18<\/jats:sup>F-FAPI-04 PET\/CT identified a greater number of primary lesions and metastatic lymph nodes compared with <jats:sup>18<\/jats:sup>F-FDG PET\/CT. <jats:sup>18<\/jats:sup>F-FAPI-04 PET\/CT detected 19\/19 primary tumors, achieving a detection rate of 100%, while <jats:sup>18<\/jats:sup>F-FDG PET\/CT identified 18\/19 primary tumors, with a detection rate of 95%. The PPV for both tracers was 100%, the NPV for <jats:sup>18<\/jats:sup>F-FDG PET\/CT was 0%. For metastatic lymph nodes, <jats:sup>18<\/jats:sup>F-FAPI-04 PET\/CT detected 82 nodes in 7 patients, while <jats:sup>18<\/jats:sup>F-FDG PET\/CT detected 44 nodes in the same 7 patients. TBR was significantly higher for <jats:sup>18<\/jats:sup>F-FAPI-04 PET\/CT compared with <jats:sup>18<\/jats:sup>F-FDGPET\/CT for primary lesions (TBR<jats:sub>blood<\/jats:sub>: 16.33 vs 9.83, <jats:italic toggle=\"yes\">P<\/jats:italic> = 0.005; TBR<jats:sub>liver<\/jats:sub>: 21.59 vs 7.04, <jats:italic toggle=\"yes\">P<\/jats:italic> &lt; 0.0001) and metastatic lymph nodes (TBR<jats:sub>blood<\/jats:sub>: 9.16 vs 7.64, <jats:italic toggle=\"yes\">P<\/jats:italic> = 0.033; TBR<jats:sub>liver<\/jats:sub>: 10.38 vs 5.29, <jats:italic toggle=\"yes\">P<\/jats:italic> &lt; 0.0001). No significant differences were observed in other semiquantitative parameters.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Conclusions:<\/jats:title>\n            <jats:p>\n                                 <jats:sup>18<\/jats:sup>F-FAPI-04 PET\/CT had superior performance in detecting primary lesions and metastatic lymph nodes in cervical cancer compared with <jats:sup>18<\/jats:sup>F-FDG PET\/CT. <jats:sup>18<\/jats:sup>F-FAPI-04 exhibited lower uptake in normal tissues, leading to a higher TBR. These findings imply that <jats:sup>18<\/jats:sup>F-FAPI-04 PET\/CT has potential for clinical application in cervical cancer.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1097\/rlu.0000000000006103","type":"journal-article","created":{"date-parts":[[2025,9,3]],"date-time":"2025-09-03T21:00:10Z","timestamp":1756933210000},"page":"983-991","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":2,"title":["18F-FAPI-04 PET\/CT in the Evaluation of Patients With Cervical Cancers"],"prefix":"10.1097","volume":"50","author":[{"given":"Jinhui","family":"Wei","sequence":"first","affiliation":[{"name":"Departments of Radiation Oncology"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kun","family":"Zou","sequence":"additional","affiliation":[{"name":"Departments of Radiation Oncology"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fangfang","family":"Sun","sequence":"additional","affiliation":[{"name":"Departments of Nuclear Medicine, The First Hospital of Dalian Medical University, Dalian"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qiaochu","family":"Feng","sequence":"additional","affiliation":[{"name":"Departments of Radiation Oncology"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haodong","family":"Liu","sequence":"additional","affiliation":[{"name":"Departments of Radiation Oncology"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hongna","family":"Zheng","sequence":"additional","affiliation":[{"name":"Departments of Nuclear Medicine, The First Hospital of Dalian Medical University, Dalian"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yanjie","family":"Guo","sequence":"additional","affiliation":[{"name":"Departments of Pathogen Biology and Microecology, Pathogen Biology laboratory, School of Basic Medical Science, Dalian Medical University, Dalian, Liaoning, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Longjie","family":"Li","sequence":"additional","affiliation":[{"name":"Departments of Radiation Oncology"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2025,8,21]]},"reference":[{"key":"R1-20251009","first-page":"209","article-title":"Global Cancer Statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"71","author":"Sung","year":"2021","journal-title":"CA Cancer J Clin"},{"key":"R2-20251009","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1016\/j.ygyno.2021.10.075","article-title":"Recent global burden of cervical cancer incidence and mortality, predictors, and temporal trends","volume":"163","author":"He","year":"2021","journal-title":"Gynecol Oncol"},{"key":"R3-20251009","first-page":"CD010260","article-title":"Hysterectomy with radiotherapy or chemotherapy or both for women with locally advanced cervical cancer","volume":"8","author":"Kokka","year":"2022","journal-title":"Cochrane Database Syst Rev"},{"key":"R4-20251009","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1002\/ijgo.12749","article-title":"Revised FIGO staging for carcinoma of the cervix uteri","volume":"145","author":"Bhatla","year":"2019","journal-title":"Int J Gynaecol Obstet"},{"key":"R5-20251009","doi-asserted-by":"crossref","first-page":"855","DOI":"10.1503\/cmaj.071124","article-title":"Diagnostic accuracy of tests for lymph node status in primary cervical cancer: a systematic review and meta-analysis","volume":"178","author":"Selman","year":"2008","journal-title":"CMAJ"},{"key":"R6-20251009","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1053\/j.semnuclmed.2019.06.007","article-title":"FDG-PET imaging in cervical cancer","volume":"49","author":"Gandy","year":"2019","journal-title":"Semin Nucl Med"},{"key":"R7-20251009","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1515\/med-2018-0065","article-title":"Meta-analysis of PET\/CT detect lymph nodes metastases of cervical cancer","volume":"13","author":"Ruan","year":"2018","journal-title":"Open Med (Wars)"},{"key":"R8-20251009","doi-asserted-by":"crossref","first-page":"109168","DOI":"10.1016\/j.biopha.2019.109168","article-title":"The impact of infection and inflammation in oncologic 18F-FDG PET\/CT imaging","volume":"117","author":"Rahman","year":"2019","journal-title":"Biomed Pharmacother"},{"key":"R9-20251009","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1007\/s10151-015-1308-3","article-title":"PET scan findings can be false positive","volume":"19","author":"Safaie","year":"2015","journal-title":"Tech Coloproctol"},{"key":"R10-20251009","doi-asserted-by":"crossref","first-page":"783","DOI":"10.1007\/s10555-020-09909-3","article-title":"The role of fibroblast activation protein in health and malignancy","volume":"39","author":"Fitzgerald","year":"2020","journal-title":"Cancer Metastasis Rev"},{"key":"R11-20251009","doi-asserted-by":"crossref","first-page":"e0116683","DOI":"10.1371\/journal.pone.0116683","article-title":"Fibroblast activation protein overexpression and clinical implications in solid tumors: a meta-analysis","volume":"10","author":"Liu","year":"2015","journal-title":"PLoS One"},{"key":"R12-20251009","doi-asserted-by":"crossref","first-page":"e1155","DOI":"10.1038\/cddis.2014.122","article-title":"Downregulation of FAP suppresses cell proliferation and metastasis through PTEN\/PI3K\/AKT and Ras-ERK signaling in oral squamous cell carcinoma","volume":"5","author":"Wang","year":"2014","journal-title":"Cell Death Dis"},{"key":"R13-20251009","doi-asserted-by":"crossref","first-page":"7235","DOI":"10.1073\/pnas.87.18.7235","article-title":"Cell surface glycoprotein of reactive stromal fibroblasts as a potential antibody target in human epithelial cancers","volume":"87","author":"Garin-Chesa","year":"1990","journal-title":"Proc Natl Acad Sci U S A"},{"key":"R14-20251009","doi-asserted-by":"crossref","first-page":"582","DOI":"10.1038\/nrc.2016.73","article-title":"The biology and function of fibroblasts in cancer","volume":"16","author":"Kalluri","year":"2016","journal-title":"Nat Rev Cancer"},{"key":"R15-20251009","doi-asserted-by":"crossref","first-page":"1820","DOI":"10.1007\/s00259-020-04769-z","article-title":"Comparison of [68Ga]Ga-DOTA-FAPI-04 and [18F] FDG PET\/CT for the diagnosis of primary and metastatic lesions in patients with various types of cancer","volume":"47","author":"Chen","year":"2020","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"R16-20251009","doi-asserted-by":"crossref","first-page":"2114","DOI":"10.1007\/s00259-023-06138-y","article-title":"The performance of 68Ga-FAPI-04 PET\/CT in head and neck squamous cell carcinoma: a prospective comparison with 18F-FDG PET\/CT","volume":"50","author":"Jiang","year":"2023","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"R17-20251009","doi-asserted-by":"crossref","first-page":"2761","DOI":"10.1007\/s00259-022-05758-0","article-title":"18F]AlF-NOTA-FAPI-04: FAP-targeting specificity, biodistribution, and PET\/CT imaging of various cancers","volume":"49","author":"Wei","year":"2022","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"R18-20251009","doi-asserted-by":"crossref","first-page":"4259","DOI":"10.1007\/s00259-021-05470-5","article-title":"Clinical translational evaluation of Al18F-NOTA-FAPI for fibroblast activation protein-targeted tumour imaging","volume":"48","author":"Wang","year":"2021","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"R19-20251009","doi-asserted-by":"crossref","first-page":"S249","DOI":"10.1016\/j.jacr.2024.02.026","article-title":"ACR appropriateness criteria pretreatment evaluation and follow-up of invasive cancer of the cervix: 2023 update","volume":"21","author":"Imaging","year":"2024","journal-title":"J Am Coll Radiol"},{"key":"R20-20251009","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/S0090-8258(03)00409-8","article-title":"Computed tomography and magnetic resonance imaging in staging of uterine cervical carcinoma: a systematic review","volume":"91","author":"Bipat","year":"2003","journal-title":"Gynecol Oncol"},{"key":"R21-20251009","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1097\/RLU.0000000000005601","article-title":"18F-AlF-NOTA-FAPI-04 superior to 18F-FDG PET\/CT in detecting primary tumor and metastatic lymph nodes in a cervical cancer patient","volume":"50","author":"Wei","year":"2025","journal-title":"Clin Nucl Med"},{"key":"R22-20251009","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1097\/RLU.0000000000004505","article-title":"First clinical experience with [68Ga]Ga-FAPI-46-PET\/CT versus [18F]F-FDG PET\/CT for nodal staging in cervical cancer","volume":"48","author":"Wegen","year":"2023","journal-title":"Clin Nucl Med"},{"key":"R23-20251009","doi-asserted-by":"crossref","first-page":"928","DOI":"10.1097\/RLU.0000000000004833","article-title":"Head-to-head comparison of 18 F-FDG and 68 Ga-FAPI-04 PET\/CT for radiological evaluation of cervical cancer","volume":"48","author":"Shu","year":"2023","journal-title":"Clin Nucl Med"},{"key":"R24-20251009","first-page":"22","article-title":"18F-FDG uptake in squamous cell carcinoma of the cervix is correlated with glucose transporter 1 expression","volume":"45","author":"Yen","year":"2004","journal-title":"J Nucl Med"},{"key":"R25-20251009","doi-asserted-by":"crossref","first-page":"3548","DOI":"10.1002\/cncr.24400","article-title":"Cervical cancer histology and tumor differentiation affect 18F-fluorodeoxyglucose uptake","volume":"115","author":"Kidd","year":"2009","journal-title":"Cancer"},{"key":"R26-20251009","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1097\/RLU.0000000000003968","article-title":"Uterine uptake of 68Ga-FAPI-04 in uterine pathology and physiology","volume":"47","author":"Zhang","year":"2022","journal-title":"Clin Nucl Med"},{"key":"R27-20251009","doi-asserted-by":"crossref","first-page":"1178","DOI":"10.1007\/s00259-020-05055-8","article-title":"Improved cancer detection in Waldeyer\u2019s tonsillar ring by 68Ga-FAPI PET\/CT imaging","volume":"48","author":"Serfling","year":"2021","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"R28-20251009","doi-asserted-by":"crossref","first-page":"1155","DOI":"10.2967\/jnumed.121.262831","article-title":"Head-to-head comparison of 68Ga-FAPI-46 and 18F-FDG PET\/CT for evaluation of head and neck squamous cell carcinoma: a single-center exploratory study","volume":"63","author":"Promteangtrong","year":"2022","journal-title":"J Nucl Med"},{"key":"R29-20251009","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1038\/s41467-019-14134-w","article-title":"Cancer-associated fibroblast heterogeneity in axillary lymph nodes drives metastases in breast cancer through complementary mechanisms","volume":"11","author":"Pelon","year":"2020","journal-title":"Nat Commun"},{"key":"R30-20251009","doi-asserted-by":"crossref","first-page":"3026","DOI":"10.1200\/JCO.2012.47.3520","article-title":"Prospective multicenter study evaluating the survival of patients with locally advanced cervical cancer undergoing laparoscopic para-aortic lymphadenectomy before chemoradiotherapy in the era of positron emission tomography imaging","volume":"31","author":"Gouy","year":"2013","journal-title":"J Clin Oncol"},{"key":"R31-20251009","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1148\/radiol.2381041799","article-title":"Lymph node metastasis in patients with clinical early-stage cervical cancer: detection with integrated FDG PET\/CT","volume":"238","author":"Sironi","year":"2006","journal-title":"Radiology"},{"key":"R32-20251009","doi-asserted-by":"crossref","first-page":"2960","DOI":"10.1007\/s00259-022-05799-5","article-title":"68[Ga]Ga-DOTA-FAPI-04 PET\/CT in the evaluation of gastric cancer: comparison with [18F]FDG PET\/CT","volume":"49","author":"Lin","year":"2022","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"R33-20251009","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1148\/radiol.211424","article-title":"Comparison of 68Ga-FAPI and 18F-FDG PET\/CT in the evaluation of advanced lung cancer","volume":"303","author":"Wang","year":"2022","journal-title":"Radiology"},{"key":"R34-20251009","doi-asserted-by":"crossref","first-page":"4089","DOI":"10.1007\/s00259-021-05378-0","article-title":"68Ga-FAPI-PET\/CT in patients with various gynecological malignancies","volume":"48","author":"Dendl","year":"2021","journal-title":"Eur J Nucl Med Mol Imaging"}],"container-title":["Clinical Nuclear Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/RLU.0000000000006103","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,9]],"date-time":"2025-10-09T16:03:48Z","timestamp":1760025828000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/RLU.0000000000006103"}},"subtitle":["Head-to-Head Comparison With 18F-FDG PET\/CT"],"short-title":[],"issued":{"date-parts":[[2025,8,21]]},"references-count":34,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2025]]}},"URL":"https:\/\/doi.org\/10.1097\/rlu.0000000000006103","relation":{},"ISSN":["0363-9762","1536-0229"],"issn-type":[{"value":"0363-9762","type":"print"},{"value":"1536-0229","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,8,21]]},"assertion":[{"value":"2025-01-23","name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2025-07-19","name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}}]}}